A modified C1q deviation radioimmunoassay for use in a routine clinical laboratory.

V. Danis,R. Trent,R. Clancy

DOI: https://doi.org/10.1016/S0022-1759(80)80007-X

1980-03-01

Abstract:

What problem does this paper attempt to address?

Effects of Hypoxemia on Gastrointestinal Blood Flow and Gastric Emptying in the Newborn Piglet

J. Szabo,B. Stonestreet,W. Oh

DOI: https://doi.org/10.1203/00006450-198505000-00012

IF: 3.953

1985-05-01

Pediatric Research

Abstract:ABSTRACT: The effects of severe hypoxemia on gastrointestinal (GI) blood flow and gastric emptying were studied in nine 2- to 4-day-old piglets which were mechanically ventilated while receiving nitrous oxide anesthesia. Each animal was studied during a control period of oxygenation (PaO2 91 ± 8 torr), 35 min of hypoxemia (PaO2 29 ± 1 torr), and a recovery period (PaO2 90 ± 5 torr) (mean ± SEM). During each study period, the animal received a 10% dextrose test meal with phenol red marker (22 ml/kg), gastric residual volumes were determined at 10-min intervals over 30-min study periods using a dye dilution double sampling technique, and GI blood flow (radionuclide- labeled microspheres), O2 delivery, O2 extraction, and O2 consumption were measured at the end of the 30- min period. Hypoxemia resulted in decreased blood flow to the following GI organs: stomach, jejunal and ileal mucosa-submucosa, and colon decreased 62, 31, and 35%, respectively (p < 0.05). Jejunal and ileal muscularis blood flow remained unchanged. Oxygen delivery and consumption by GI tract decreased 79 and 58%, respectively; whereas oxygen extraction of GI tract increased 115%. Values returned toward baseline levels during the recovery period. The hypoxemic gastric emptying pattern showed significantly greater gastric residuals at 20 min compared to the 10-min value (P < 0.05). This pattern was different than that observed during control and recovery periods. We conclude that severe hypoxemia results in decreased GI blood flow, tissue oxygenation, and an altered gastric emptying pattern. These observations may have clinical significance for feeding infants following an hypoxemic episode.
A WNT mimetic with broad spectrum FZD-specificity decreases fibrosis and improves function in a pulmonary damage model

Mehaben Patel,Yorick Post,Natalie Hill,Asmiti Sura,Jay Ye,Trevor Fisher,Nicholas Suen,Mengrui Zhang,Leona Cheng,Ariel Pribluda,Hui Chen,Wen-Chen Yeh,Yang Li,Hélène Baribault,Russell B. Fletcher

DOI: https://doi.org/10.1186/s12931-024-02786-2

IF: 5.8

2024-04-04

Respiratory Research

Abstract:Wnt/β-catenin signaling is critical for lung development and AT2 stem cell maintenance in adults, but excessive pathway activation has been associated with pulmonary fibrosis, both in animal models and human diseases such as idiopathic pulmonary fibrosis (IPF). IPF is a detrimental interstitial lung disease, and although two approved drugs limit functional decline, transplantation is the only treatment that extends survival, highlighting the need for regenerative therapies.

respiratory system
Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

M Lehmann,Q Hu,Y Hu,R Costa,M Ansari,R Pineda,W Janssen,F Theis,H Schiller,M Königshoff

DOI: https://doi.org/10.1183/23120541.LSC-2020.81

IF: 4.239

2020-01-01

ERJ Open Research

Abstract:Introduction: Idiopathic Pulmonary Fibrosis (IPF) is an age-related disease, which displays several hallmarks of aging, such as cellular senescence. The lung epithelium represents a major site of tissue injury in IPF resulting in functional changes including aberrant activity of the developmental WNT/β-catenin pathway. The potential impact of WNT/β-catenin signaling on epithelial senescence in aging and IPF remains elusive. Methods: Single Cell RNA Sequencing (scRNAseq) from EpCAM-enriched cell populations was performed from IPF and donor lungs. RNAseq, qPCR and flow cytometry was applied to characterize ATII cells from young (3 months) and old (18 months) wild-type or WNT-reporter mice, respectively. Progenitor cell potential was investigated by organoid assay. ATII cells were treated with WNT3A for up to 7 days. Cellular senescence was monitored by qPCR and senescence-associated s-Galactosidase activity. Results: ScRNAseq revealed a concomitant enrichment of both WNT/β-catenin signaling and cellular senescence in distinct cell populations in IPF. Similarly, aged ATII cells showed increased cellular senescence and increased WNT/β-catenin activity. Moreover, aged ATII cells exhibit an impaired organoid forming capacity. Bulk RNA sequencing revealed 416 differentially expressed genes in aged ATII cells, many of which are further known to be dysregulated in fibrosis. Chronic WNT/β-catenin activation induced cellular senescence in primary ATII cells. Simultaneously, chronic but not acute WNT activation induced a profibrotic state with increased expression of the impaired ATII cell marker Keratin8. Conclusions: These results suggest that WNT/β-catenin signaling contributes to progenitor cell dysfunction and impaired lung repair in the aged lung, which is further enhanced in IPF.
Therapeutic Targeting of Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis

Meng Hu,Pulin Che,Xiaosi Han,Guo-Qiang Cai,Gang Liu,Veena Antony,Tracy Luckhardt,Gene P. Siegal,Yong Zhou,Rui-Ming Liu,Leena P. Desai,Philip J. O'Reilly,Victor J. Thannickal,Qiang Ding

DOI: https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1944

2014-01-01

Journal of Pharmacology and Experimental Therapeutics

Abstract:Myofibroblasts are effector cells in fibrotic disorders that synthesize and remodel the extracellular matrix (ECM). This study investigated the role of the Src kinase pathway in myofibroblast activation in vitro and fibrogenesis in vivo. The profibrotic cytokine, transforming growth factor beta 1 (TGF-beta 1), induced rapid activation of Src kinase, which led to myofibroblast differentiation of human lung fibroblasts. The Src kinase inhibitor AZD0530 (saracatinib) blocked TGF-beta 1-induced Src kinase activation in a dose-dependent manner. Inhibition of Src kinase significantly reduced a-smooth muscle actin (alpha-SMA) expression, a marker of myofibroblast differentiation, in TGF-beta 1- treated lung fibroblasts. In addition, the induced expression of collagen and fibronectin and three-dimensional collagen gel contraction were also significantly inhibited in AZD0530-treated fibroblasts. The therapeutic efficiency of Src kinase inhibition in vivo was tested in the bleomycin murine lung fibrosis model. Src kinase activation and collagen accumulation were significantly reduced in the lungs of AZD0530-treated mice when compared with controls. Furthermore, the total fibrotic area and expression of alpha-SMA and ECM proteins were significantly decreased in lungs of AZD0530-treated mice. These results indicate that Src kinase promotes myofibroblast differentiation and activation of lung fibroblasts. Additionally, these studies provide proof-of-concept for targeting the noncanonical TGF-beta signaling pathway involving Src kinase as an effective therapeutic strategy for lung fibrosis.
Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice

Shi-xia Cai,Ai-ran Liu,Song Chen,Hong-li He,Qi-hong Chen,Jing-yuan Xu,Chun Pan,Yi Yang,Feng-mei Guo,Ying-zi Huang,Ling Liu,Hai-bo Qiu

DOI: https://doi.org/10.1186/s13287-015-0060-y

2015-04-11

Abstract:Introduction: Mesenchymal stem cells (MSCs) have potential for re-epithelization and recovery in acute respiratory distress syndrome (ARDS). In a previous in vitro study, the results showed that the canonical Wnt/β-catenin pathway promoted the differentiation of MSCs into type II alveolar epithelial cells, conferred resistance to oxidative stress, and promoted their migration, suggesting that the Wnt/β-catenin pathway might be one of the key mechanisms underling the therapeutic effect of mouse MSCs in ARDS. Methods: Mouse MSCs stable transfected with β-catenin or green fluorescent protein control were transplanted intratracheally into the ARDS mice induced by lipopolysaccharide. Lung tissue injury and repair assessment were examined using haematoxylin and eosin staining, lung injury scoring, Masson's trichrome staining and fibrosis scoring. Homing and differentiation of mouse MSCs were assayed by labelling and tracing MSCs using NIR815 dye, immunofluorescent staining, and Western immunoblot analysis. The inflammation and permeability were evaluated by detecting the cytokine and protein measurements in bronchoalveolar lavage fluid using enzyme-linked immunosorbent assay. Results: In this study, β-catenin-overexpressing MSC engraftment led to more significant effects than the GFP controls, including the retention of the MSCs in the lung, differentiation into type II alveolar epithelial cells, improvement in alveolar epithelial permeability, and the pathologic impairment of the lung tissue. Conclusion: These results suggest that the activation of canonical Wnt/β-catenin pathway by mouse MSCs by overexpressing β-catenin could further improve the protection of mouse MSCs against epithelial impair and the therapeutic effects of mouse MSCs in ARDS mice.
Retraction Note: Activation of Wnt/β-catenin Signalling Promotes Mesenchymal Stem Cells to Repair Injured Alveolar Epithelium Induced by Lipopolysaccharide in Mice

Shi-xia Cai,Ai-ran Liu,Song Chen,Hong-li He,Qi-hong Chen,Jing-yuan Xu,Chun Pan,Yi Yang,Feng-mei Guo,Ying-zi Huang,Ling Liu,Hai-bo Qiu

DOI: https://doi.org/10.1186/s13287-015-0060-y

2015-01-01

Stem Cell Research & Therapy

Abstract:INTRODUCTION:Mesenchymal stem cells (MSCs) have potential for re-epithelization and recovery in acute respiratory distress syndrome (ARDS). In a previous in vitro study, the results showed that the canonical Wnt/β-catenin pathway promoted the differentiation of MSCs into type II alveolar epithelial cells, conferred resistance to oxidative stress, and promoted their migration, suggesting that the Wnt/β-catenin pathway might be one of the key mechanisms underling the therapeutic effect of mouse MSCs in ARDS.METHODS:Mouse MSCs stable transfected with β-catenin or green fluorescent protein control were transplanted intratracheally into the ARDS mice induced by lipopolysaccharide. Lung tissue injury and repair assessment were examined using haematoxylin and eosin staining, lung injury scoring, Masson's trichrome staining and fibrosis scoring. Homing and differentiation of mouse MSCs were assayed by labelling and tracing MSCs using NIR815 dye, immunofluorescent staining, and Western immunoblot analysis. The inflammation and permeability were evaluated by detecting the cytokine and protein measurements in bronchoalveolar lavage fluid using enzyme-linked immunosorbent assay.RESULTS:In this study, β-catenin-overexpressing MSC engraftment led to more significant effects than the GFP controls, including the retention of the MSCs in the lung, differentiation into type II alveolar epithelial cells, improvement in alveolar epithelial permeability, and the pathologic impairment of the lung tissue.CONCLUSION:These results suggest that the activation of canonical Wnt/β-catenin pathway by mouse MSCs by overexpressing β-catenin could further improve the protection of mouse MSCs against epithelial impair and the therapeutic effects of mouse MSCs in ARDS mice.
Blocking the Wnt/β-Catenin Pathway by Lentivirus-Mediated Short Hairpin RNA Targeting β-Catenin Gene Suppresses Silica-Induced Lung Fibrosis in Mice

Xin Wang,Wujing Dai,Yanrang Wang,Qing Gu,Deyi Yang,Ming Zhang

DOI: https://doi.org/10.3390/ijerph120910739

IF: 4.614

2015-09-01

International Journal of Environmental Research and Public Health

Abstract:Silicosis is a form of occupational lung disease caused by inhalation of crystalline silica dust. While the pathogenesis of silicosis is not clearly understood, the Wnt/β-catenin signaling pathway is thought to play a major role in lung fibrosis. To explore the role of Wnt/β-catenin pathway in silicosis, we blocked Wnt/β-catenin pathway both in silica-treated MLE-12 cells (a mouse pulmonary epithelial cell line) and in a mouse silicosis model by using a lentiviral vector expressing a short hairpin RNA silencing β-catenin (Lv-shβ-catenin). In vitro, Lv-shβ-catenin significantly decreased the expression of β-catenin, MMP2 and MMP9, and secretion of TGF-β1. In vivo, intratracheal treatment with Lv-shβ-catenin significantly reduced expression of β-catenin in the lung and levels of TGF-β1 in bronchoalveolar lavage fluid, and notably attenuated pulmonary fibrosis as evidenced by hydroxyproline content and collagen I\III synthesis in silica-administered mice. These results indicate that blockade of the Wnt/β-catenin pathway can prevent the development of silica-induced lung fibrosis. Thus Wnt/β-catenin pathway may be a target in prevention and treatment of silicosis.

public, environmental & occupational health,environmental sciences
Wnt8b regulates myofibroblast differentiation of lung-resident mesenchymal stem cells via the activation of Wnt/β-catenin signaling in pulmonary fibrogenesis

Chaowen Shi,Xiang Chen,Wenna Yin,Zhaorui Sun,Jiwei Hou,Xiaodong Han

DOI: https://doi.org/10.1016/j.diff.2022.03.004

IF: 3.533

2022-05-01

Differentiation

Abstract:Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal lung disease that is characterized by enhanced changes in stem cell differentiation and fibroblast proliferation. Lung resident mesenchymal stem cells (LR-MSCs) are important regulators of pathophysiological processes including tissue repair and inflammation, and evidence suggests that this cell population also plays an essential role in fibrosis. Our previous study demonstrated that Wnt/β-catenin signaling is aberrantly activated in the lungs of bleomycin-treated mice and induces myofibroblast differentiation of LR-MSCs. However, the underlying correlation between LR-MSCs and the Wnt/β-catenin signaling remains poorly understood. We found that Wnt8b was highly expressed by LR-MSCs undergoing myofibroblast differentiation. In vitro, Wnt8b promoted LR-MSCs differentiate into myofibroblasts via activating Wnt/β-catenin signaling. Moreover, siRNA-mediated inhibition of Wnt8b prevented Transforming growth factor (TGF)-β1-induced myofibroblast differentiation of LR-MSCs in vitro and ameliorated pulmonary fibrotic lesions. Our study identified Wnt proteins and Wnt/β-catenin signaling in pulmonary fibrosis in vitro and in vivo, and highlighted Wnt8b as a potential therapeutic target in pulmonary fibrosis. Moreover, these finding might provide a new perspective in the development of treatment strategies for IPF.

cell biology,developmental biology
AHR activation accelerates the resolution of TGF-β1 induced fibroblast activation and promotes alveolar type 1 cell regeneration in alveolar organoids

Andrew S. Hagan,Scott Williams,Casey J. N. Mathison,Shanshan Yan,Bao Nguyen,Glenn C. Federe,Guray Kuzu,Joseph C. Siefert,Janice Hampton,Victor Chichkov,S. Whitney Barnes,Frederick J. King,Brandon Taylor,John R. Walker,Rui Zhao,Jimmy Elliott,Dean P. Phillips,Bin Fang,Rebekah S. Decker

DOI: https://doi.org/10.1101/2024.04.29.590972

2024-05-02

Abstract:Regeneration of the alveolar epithelium is necessary to restore tissue architecture and gas exchange capabilities in chronic pulmonary diseases such as fibrosing interstitial lung disease. While it is known alveolar type 2 (AT2) cells give rise to alveolar type 1 (AT1) cells to repair the alveolar epithelium after injury, methods to promote this process under pathological settings are poorly understood. Here, using a complex 3D organoid culture with TGF-β1 dependent impaired AT1 spheroid formation, we performed a high-throughput screen (HTS) with ∼16,800 compounds to identify small molecules that increase number of AT1 spheroids. Longitudinal single cell RNA sequencing (scRNA-seq) revealed that DB-11-BE87 increased AT1 regeneration by reducing TGF-β1 induced fibroblast activation, concurrently with AHR activation in those cells. These studies highlight a novel HTS system to identify factors that can promote AT1 differentiation and suggest AHR activation as a method to counteract pathological TGF-β1 signaling in pulmonary disease.

Cell Biology
Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis

ZHAORUI SUN,CONG WANG,CHAOWEN SHI,FANGFANG SUN,XIAOMENG XU,WEIPING QIAN,SHINAN NIE,XIAODONG HAN

DOI: https://doi.org/10.3892/ijmm.2014.1672

IF: 5.314

2014-02-25

International Journal of Molecular Medicine

Abstract:Acute lung injury may lead to fibrogenesis. However, no treatment is currently available. This study was conducted to determine the effects of bone marrow-derived mesenchymal stem cells (MSCs) in a model of HCl-induced acute lung injury in Sprague-Dawley (SD) rats. Stromal cell-derived factor (SDF)-1 and its receptor CXC chemokine receptor (CXCR)4 have been shown to participate in mobilizing MSCs. Adenovirus carrying the CXCR4 gene was used to transfect MSCs in order to increase the engraftment numbers of MSCs at injured sites. Histological examination data demonstrated that the engraftment of MSCs did not attenuate lung injury and pulmonary fibrosis. The results showed that engraftment of MSCs almost differentiated into myofibroblasts, but rarely differentiated into lung epithelial cells. Additionally, it was demonstrated that activated canonical Wnt/β-catenin signaling in injured lung tissue regulated the myofibroblast differentiation of MSCs in vivo. The in vitro study results demonstrated that activation of the Wnt/β-catenin signaling stimulated MSCs to express myofibroblast markers; however, this process was attenuated by Wnt antagonist DKK1. Therefore, the results demonstrated that the aberrant activation of Wnt signaling induces the myofibroblast differentiation of engrafted MSCs, thus contributing to pulmonary fibrosis following lung injury.

medicine, research & experimental
Targeted Inhibition of Disheveled PDZ Domain Via NSC668036 Depresses Fibrotic Process.

Cong Wang,Jinghong Dai,Zhaorui Sun,Chaowen Shi,Honghui Cao,Xiang Chen,Shen Gu,Zutong Li,Weiping Qian,Xiaodong Han

DOI: https://doi.org/10.1016/j.yexcr.2014.10.023

IF: 4.145

2015-01-01

Experimental Cell Research

Abstract:In this study, we determined the effects of transforming growth factor-beta (TGF-β) and Wnt/β-catenin signaling on myofibroblast differentiation of NIH/3T3 fibroblasts in vitro and evaluated the therapeutic efficacy of NSC668036 in bleomycin-induced pulmonary fibrosis murine model. In vitro study, NSC668036, a small organic inhibitor of the PDZ domain in Dvl, suppressed β-catenin-driven gene transcription and abolished TGF-β1-induced migration, expression of collagen I and α-smooth muscle actin (α-SMA) in fibroblasts. In vivo study, we found that NSC668036 significantly suppressed accumulation of collagen I, α-SMA, and TGF-β1 but increased the expression of CK19, Occludin and E-cadherin that can inhibit pulmonary fibrogenesis. Because fibrotic lung exhibit aberrant activation of Wnt/β-catenin signaling, these data collectively suggest that inhibition of Wnt/β-catenin signaling at the Dvl level may be an effective approach to the treatment of fibrotic lung diseases.
Inhibition of Wnt10b/β-catenin signaling alleviates pulmonary fibrogenesis induced by paraquat in vivo and in vitro

Zhizhou Yang,Mengmeng Wang,Yi Ren,Liang Li,Liping Cao,Wei Zhang,Kongbo Lv,Zhaorui Sun,Shinan Nie

DOI: https://doi.org/10.1016/j.lfs.2021.120027

IF: 6.78

2021-12-01

Life Sciences

Abstract:Pulmonary fibrosis (PF) caused by paraquat remains a critical issue, and the molecular mechanisms are still unclear. Epithelial-mesenchymal transition (EMT) is regarded as a hallmark of PF, conferring alveolar epithelial cells partial mesenchymal characteristics, facilitating migration, expressing excessive extracellular matrix components, and participating in lung parenchyma remodeling and stiffening. Aberration of Wnt signaling has been identified in EMT and PF, and Wnt protein family consists of 19 ligands. The relationship of the specific Wnt ligands and fibrogenesis induced by PQ was not well defined. In current study, PQ-induced lung fibrosis rat model and EMT cell model were utilized to investigate the underlying molecular mechanisms both in vivo and in vitro. The results demonstrated that canonical Wnt/β-catenin signaling was highly activated and Wnt10b was the most affected. Additionally, suppression of Wnt10b by RNA interference could reverse EMT in vitro and detain the process of PF in vivo. These data establish Wnt10b as the key regulator of EMT and lung fibrogenesis, and suggest the potential of targeted interference against Wnt10b as a promising therapeutic strategy for lung fibrosis.

pharmacology & pharmacy,medicine, research & experimental
Wnt/β-catenin signaling is critical for regenerative potential of distal lung epithelial progenitor cells in homeostasis and emphysema

Yan Hu,John‐Poul Ng‐Blichfeldt,Chiharu Ota,Chiara Ciminieri,Wenhua Ren,Pieter S. Hiemstra,Jan Stolk,Reinoud Gosens,Melanie Königshoff,John-Poul Ng-Blichfeldt

DOI: https://doi.org/10.1002/stem.3241

IF: 5.845

2020-06-18

Stem Cells

Abstract:Abstract Wnt/β-catenin signaling regulates progenitor cell fate decisions during lung development and in various adult tissues. Ectopic activation of Wnt/β-catenin signaling promotes tissue repair in emphysema, a devastating lung disease with progressive loss of parenchymal lung tissue. The identity of Wnt/β-catenin responsive progenitor cells and the potential impact of Wnt/β-catenin signaling on adult distal lung epithelial progenitor cell function in emphysema are poorly understood. Here, we used TCF/Lef:H2B/GFP reporter mice to investigate the role of Wnt/β-catenin signaling in lung organoid formation. We identified an organoid-forming adult distal lung epithelial progenitor cell population characterized by a low Wnt/β-catenin activity, which was enriched in club and alveolar epithelial type (AT)II cells. Endogenous Wnt/β-catenin activity was required for the initiation of multiple subtypes of distal lung organoids derived from the Wntlow epithelial progenitors. Further ectopic Wnt/β-catenin activation specifically led to an increase in alveolar organoid number; however, the subsequent proliferation of alveolar epithelial cells in the organoids did not require constitutive Wnt/β-catenin signaling. Distal lung epithelial progenitor cells derived from the mouse model of elastase-induced emphysema exhibited reduced organoid forming capacity. This was rescued by Wnt/β-catenin signal activation, which largely increased the number of alveolar organoids. Together, our study reveals a novel mechanism of lung epithelial progenitor cell activation in homeostasis and emphysema.

oncology,cell biology,hematology,biotechnology & applied microbiology,cell & tissue engineering
Umbilical cord mesenchymal stem cells overexpressing CXCR7 facilitate treatment of ARDS-associated pulmonary fibrosis via inhibition of Notch/Jag1 mediated by the Wnt/β-catenin pathway

Kun Xiao,Chang Liu,Heming Wang,Fei Hou,Yinghan Shi,Zhi Rong Qian,Hao Zhang,David Y B Deng,Lixin Xie

DOI: https://doi.org/10.1016/j.biopha.2023.115124

Abstract:The therapeutic efficacy of umbilical cord mesenchymal stem cells (UCMSCs) in acute respiratory distress syndrome (ARDS) is mainly limited by the efficiency of homing of UCMSCs toward tissue damage. C-X-C chemokine receptor type 7 (CXCR7), which is involved in the mobilization of UCMSCs, is only expressed on the surface of a small proportion of UCMSCs. This study examined whether overexpression of CXCR7 in UCMSCs (UCMSCsOE-CXCR7) could improve their homing efficiency, and therefore, improve their effectiveness in fibrosis repair at the site of lung injury caused by ARDS. A lentiviral vector expressing CXCR7 was built and then transfect into UCMSCs. The impacts of CXCR7 expression of the proliferationand homing of UCMSCs were examined in a lipopolysaccharide-induced ARDS mouse model. The potential role and underlying mechanism of CXCR7 were examined by performing scratch assays, transwell assays, and immunoassays. The therapeutic dose and treatment time of UCMSCsOE-CXCR7 were directly proportional to their therapeutic effect on lung injury. In addition, overexpression of CXCR7 increased SDF-1-induced proliferation and migration of lung epithelial cells (Base-2b cells), and upregulation of CXCR7 inhibited α-SMA expression, suggesting that CXCR7 may have a role in alleviating pulmonary fibrosis caused by ARDS. Overexpression of CXCR7 in UCMSCs may improve their therapeutic effect of acute lung injury mouse, The mechanism of fibrosis repair by CXCR7 is inhibition of Jag1 via suppression of the Wnt/β-catenin pathway under the chemotaxis of SDF-1.
α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B signaling in acute lung injury

Xiaoyan Chen,Cuiping Zhang,Tianchang Wei,Jie Chen,Ting Pan,Miao Li,Lu Wang,Juan Song,Cuicui Chen,Yan Zhang,Yuanlin Song,Xiao Su

DOI: https://doi.org/10.1172/jci.insight.162547

IF: 9.4958

2023-08-09

JCI Insight

Abstract:Reducing inflammatory damage and improving alveolar epithelium regeneration are two key approaches to promoting lung repair in acute lung injury/acute respiratory distress syndrome (ALI/ARDS). Stimulation of cholinergic α7 nicotinic acetylcholine receptor (α7nAChR, coded by Chrna7 ) signaling could dampen lung inflammatory injury. However, whether activation of α7nAChR in alveolar type II (AT2) cells promotes alveolar epithelial injury repair and underlying mechanisms is elusive. Here, we found that α7nAChR was expressed on AT2 cells and was upregulated in response to LPS-induced ALI. Meanwhile, deletion of Chrna7 in AT2 cells impeded lung repair process and worsened lung inflammation in ALI. Using in vivo AT2 lineage–labeled mice and ex vivo AT2 cell–derived alveolar organoids, we demonstrated that activation of α7nAChR expressed on AT2 cells improved alveolar regeneration by promoting AT2 cells to proliferate and subsequently differentiate toward alveolar type I cells. Then, we screened out the WNT7B signaling pathway by the RNA-Seq analysis of in vivo AT2 lineage–labeled cells and further confirmed its indispensability for α7nAChR activation–mediated alveolar epithelial proliferation and differentiation. Thus, we have identified a potentially unrecognized pathway in which cholinergic α7nAChR signaling determines alveolar regeneration and repair, which might provide us a novel therapeutic target for combating ALI.

medicine, research & experimental
Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice

Lifang Wang,Yuxiang Wang,Tuo Yang,Yanfei Guo,Tieying Sun

DOI: https://doi.org/10.1159/000430131

2015-01-01

Cellular Physiology and Biochemistry

Abstract:Background: Local renin-angiotensin system (RAS) activation has been shown to play an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). It has been reported that angiotensin-converting enzyme 2 (ACE2) could inhibit RAS-mediated epithelial injury and fibrogenesis and that ACE2 deficiency could aggravate acute and chronic lung injury. Through research, it could be deduced that ACE2 could protect against pulmonary fibrosis as a therapeutic target. Methods: Time-course analysis of the pathological characteristics of bleomycin-induced lung fibrosis was undertaken in a mouse model, and the effect of exogenous ACE2 on lung fibrosis was studied. Immunohistchemistry (IHC) staining and western blot (WB) testing for AGT and ACE2 were performed to evaluate the regulation of local RAS. TUNEL staining was used to observe epithelial apoptosis. Leukocyte common antigen (LCA) and pulmonary surfactant-associated protein A (SP-A) IHC staining and WB testing were performed to assess the inflammatory response and epithelial regeneration. Masson's staining and a hydroxyproline assay were performed to examine collagen deposition. IHC staining and WB testing for TGF-β1 and α-SMA were performed to investigate the regulation of pro-fibrotic cytokines and the activation of fibroblasts. Results: Exogenous ACE2 attenuated bleomycin-induced lung fibrosis by reversing the reduction of local ACE2 and by suppressing the elevation of AGT. ACE2 decreased the apoptosis index and LCA levels and ameliorated the dynamic change in SP-A level, thus protecting against epithelial injury. Reductions of TGF-β1 and α-SMA were also found in ACE2-treated mice, indicating the inhibition of fibrogenesis. Conclusion: ACE2 attenuated bleomycin-induced lung fibrosis as an anti-inflammatory anti-apoptotic and anti-fibrotic agent, and it might be a promising therapeutic target for IPF.
Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk

Tsukasa Kadota,Yu Fujita,Jun Araya,Naoaki Watanabe,Shota Fujimoto,Hironori Kawamoto,Shunsuke Minagawa,Hiromichi Hara,Takashi Ohtsuka,Yusuke Yamamoto,Kazuyoshi Kuwano,Takahiro Ochiya

DOI: https://doi.org/10.1002/jev2.12124

2021-08-01

Journal of Extracellular Vesicles

Abstract:Idiopathic pulmonary fibrosis (IPF) is characterized by devastating and progressive lung parenchymal fibrosis, resulting in poor patient prognosis. An aberrant recapitulation of developmental lung gene expression, including genes for transforming growth factor (TGF)-β and WNT, has been widely implicated in the pathogenic IPF wound healing process that results from repetitive alveolar epithelial injury. Extracellular vesicles (EVs) have been shown to carry bioactive molecules and to be involved in various physiological and pathological processes. Here, we demonstrate that, by attenuating WNT signalling, human bronchial epithelial cell-derived EVs (HBEC EVs) inhibit TGF-β mediated induction of both myofibroblast differentiation and lung epithelial cellular senescence. This effect of HBEC EVs is more pronounced than that observed with mesenchymal stem cell-derived EVs. Mechanistically, the HBEC EV microRNA (miRNA) cargo is primarily responsible for attenuating both myofibroblast differentiation and cellular senescence. This attenuation occurs via inhibition of canonical and non-canonical WNT signalling pathways. Among enriched miRNA species present in HBEC EVs, miR-16, miR-26a, miR-26b, miR-141, miR-148a, and miR-200a are mechanistically involved in reducing WNT5A and WNT10B expression in LFs, and in reducing WNT3A, WNT5A, and WNT10B expression in HBECs. Mouse models utilizing intratracheal administration of EVs demonstrate efficient attenuation of bleomycin-induced lung fibrosis development accompanied by reduced expression of both β-catenin and markers of cellular senescence. These findings indicate that EVs derived from normal resident lung HBECs may possess anti-fibrotic properties. They further suggest that, via miRNA-mediated inhibition of TGF-β-WNT crosstalk, HBEC EVs administration can be a promising anti-fibrotic modality of treatment for IPF.

cell biology
Wnt3a‐Loaded Extracellular Vesicles Promote Alveolar Epithelial Regeneration after Lung Injury (Adv. Sci. 18/2023)

Lei Gao,Yongping Sun,Xinye Zhang,Ding Ma,An Xie,Enyu Wang,Linzhao Cheng,Senquan Liu

DOI: https://doi.org/10.1002/advs.202370116

IF: 15.1

2023-06-23

Advanced Science

Abstract:Wnt3a‐Loaded Extracellular Vesicles In article number 2206606, Linzhao Cheng, Senquan Liu, and co‐workers devise a novel approach to deliver hydrophobic Wnt3a by anchoring it to the surface of extracellular vesicles (EVs). The therapeutic functions of engineered EVs are validated by experimental lung injury models. EV‐based Wnt signaling activation may represent a valuable therapeutic strategy for tissue regeneration and repair after injury.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

Kai-Wei Chang,Xiang Zhang,Shih-Chao Lin,Yu-Chao Lin,Chia-Hsiang Li,Ivan Akhrymuk,Sheng-Hao Lin,Chi-Chien Lin

DOI: https://doi.org/10.3390/ijms222011152

IF: 5.6

2021-10-15

International Journal of Molecular Sciences

Abstract:Idiopathic pulmonary fibrosis (IPF) is characterized by fibrotic change in alveolar epithelial cells and leads to the irreversible deterioration of pulmonary function. Transforming growth factor-beta 1 (TGF-β1)-induced epithelial-mesenchymal transition (EMT) in type 2 lung epithelial cells contributes to excessive collagen deposition and plays an important role in IPF. Atractylodin (ATL) is a kind of herbal medicine that has been proven to protect intestinal inflammation and attenuate acute lung injury. Our study aimed to determine whether EMT played a crucial role in the pathogenesis of pulmonary fibrosis and whether EMT can be utilized as a therapeutic target by ATL treatment to mitigate IPF. To address this topic, we took two steps to investigate: 1. Utilization of anin vitro EMT model by treating alveolar epithelial cells (A549 cells) with TGF-β1 followed by ATL treatment for elucidating the underlying pathways, including Smad2/3 hyperphosphorylation, mitogen-activated protein kinase (MAPK) pathway overexpression, Snail and Slug upregulation, and loss of E-cadherin. Utilization of an in vivo lung injury model by treating bleomycin on mice followed by ATL treatment to demonstrate the therapeutic effectiveness, such as, less collagen deposition and lower E-cadherin expression. In conclusion, ATL attenuates TGF-β1-induced EMT in A549 cells and bleomycin-induced pulmonary fibrosis in mice.

biochemistry & molecular biology,chemistry, multidisciplinary
The sulfhydryl oxidase Erv1 is a substrate of the Mia40‐dependent protein translocation pathway

N. Terziyska,Barbara Grumbt,Melanie Bien,W. Neupert,J. Herrmann,K. Hell

DOI: https://doi.org/10.1016/j.febslet.2007.02.014

2007-03-20

FEBS Letters

Abstract:

A modified C1q deviation radioimmunoassay for use in a routine clinical laboratory.

Effects of Hypoxemia on Gastrointestinal Blood Flow and Gastric Emptying in the Newborn Piglet

A WNT mimetic with broad spectrum FZD-specificity decreases fibrosis and improves function in a pulmonary damage model

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

Therapeutic Targeting of Src Kinase and Myofibroblast Activation in Pulmonary Fibrosis

Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice

Retraction Note: Activation of Wnt/β-catenin Signalling Promotes Mesenchymal Stem Cells to Repair Injured Alveolar Epithelium Induced by Lipopolysaccharide in Mice

Blocking the Wnt/β-Catenin Pathway by Lentivirus-Mediated Short Hairpin RNA Targeting β-Catenin Gene Suppresses Silica-Induced Lung Fibrosis in Mice

Wnt8b regulates myofibroblast differentiation of lung-resident mesenchymal stem cells via the activation of Wnt/β-catenin signaling in pulmonary fibrogenesis

AHR activation accelerates the resolution of TGF-β1 induced fibroblast activation and promotes alveolar type 1 cell regeneration in alveolar organoids

Activated Wnt signaling induces myofibroblast differentiation of mesenchymal stem cells, contributing to pulmonary fibrosis

Targeted Inhibition of Disheveled PDZ Domain Via NSC668036 Depresses Fibrotic Process.

Inhibition of Wnt10b/β-catenin signaling alleviates pulmonary fibrogenesis induced by paraquat in vivo and in vitro

Wnt/β-catenin signaling is critical for regenerative potential of distal lung epithelial progenitor cells in homeostasis and emphysema

Umbilical cord mesenchymal stem cells overexpressing CXCR7 facilitate treatment of ARDS-associated pulmonary fibrosis via inhibition of Notch/Jag1 mediated by the Wnt/β-catenin pathway

α7nAChR activation in AT2 cells promotes alveolar regeneration through WNT7B signaling in acute lung injury

Angiotensin-Converting Enzyme 2 Attenuates Bleomycin-Induced Lung Fibrosis in Mice

Human bronchial epithelial cell‐derived extracellular vesicle therapy for pulmonary fibrosis via inhibition of TGF‐β‐WNT crosstalk

Wnt3a‐Loaded Extracellular Vesicles Promote Alveolar Epithelial Regeneration after Lung Injury (Adv. Sci. 18/2023)

Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

The sulfhydryl oxidase Erv1 is a substrate of the Mia40‐dependent protein translocation pathway